Your browser doesn't support javascript.
loading
Quality of life among women diagnosed with breast Cancer: A randomized waitlist controlled trial of commercially available mobile app-delivered mindfulness training.
Rosen, Kristen D; Paniagua, Samantha M; Kazanis, William; Jones, Shaun; Potter, Jennifer Sharpe.
  • Rosen KD; Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
  • Paniagua SM; Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
  • Kazanis W; Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
  • Jones S; Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
  • Potter JS; Department of Psychiatry, University of Texas Health Science Center San Antonio, San Antonio, TX, USA.
Psychooncology ; 27(8): 2023-2030, 2018 08.
Article en En | MEDLINE | ID: mdl-29766596
ABSTRACT

OBJECTIVE:

The primary objective was to evaluate the efficacy of commercially available mobile app-delivered mindfulness training (AMT), compared with waitlist control (WC), on quality of life (QOL) among women diagnosed with breast cancer. The secondary outcome was dispositional mindfulness. Enrollment, app utilization, and study completion are reported as feasibility objectives.

METHODS:

Women diagnosed with breast cancer ≤5 years (n = 112) were randomized to AMT (n = 57) or WC (n = 55), over 8 weeks, with 4 weeks of follow-up. We conducted linear mixed effects models to examine group by observation interactions on QOL and dispositional mindfulness at baseline, during intervention (5-weeks), post-intervention (9-weeks), and follow-up (12-weeks post-baseline).

RESULTS:

Participants assigned to AMT reported higher QOL, compared with those assigned to WC, from baseline through follow-up t(258.40) = 3.09, P < 0.01, 95% CI [2.71, 11.90]. Participants assigned to AMT also reported higher dispositional mindfulness, compared with those assigned to WC, from baseline through follow-up t(268.44) = 2.04, P = 0.04, 95% CI [0.01, 0.57]. App utilization data was obtained from 34 participants. Fewer participants assigned to AMT completed all study assessments, compared with participants assigned to WC, (χ21  = 7.07, P = 0.008).

CONCLUSIONS:

Findings suggest commercially available AMT may proffer some benefit to women seeking to enhance their QOL following breast cancer diagnosis.
Asunto(s)
Palabras clave

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Estrés Psicológico / Neoplasias de la Mama / Atención Plena / Aplicaciones Móviles Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Calidad de Vida / Estrés Psicológico / Neoplasias de la Mama / Atención Plena / Aplicaciones Móviles Tipo de estudio: Clinical_trials / Diagnostic_studies / Prognostic_studies Límite: Adult / Female / Humans / Middle aged Idioma: En Año: 2018 Tipo del documento: Article